Glaucoma is a neuropathic disease that causes optic nerve damage, loss of retinal ganglion
cells (RGCs), and visual field defects. Most glaucoma patients have no early signs or …

Neuroprotection is a therapeutic strategy directed at keeping retinal ganglion cells (RGCs)
alive and functional. This article discusses three commonly asked questions about …

Glaucoma is a progressive neurodegenerative disease that frequently results in irreversible
blindness. Glaucoma causes death of retinal ganglion cells (RGCs) and their axons in the …

The purpose of this article is to summarize our current knowledge about the susceptibility of
specific retinal ganglion cell (RGC) types in experimental glaucoma, and to delineate the …

A hallmark of glaucomatous optic nerve damage is retinal ganglion cell (RGC) death. RGCs,
like other central nervous system neurons, have a limited capacity to survive or regenerate …

Glaucoma is a neurodegenerative disease that affects primarily the retinal ganglion cells
(RGCs). Increased intraocular pressure (IOP) is one of the major risk factors for glaucoma …

Glaucoma is a complex neurodegenerative disease that involves interactions among
multiple signaling pathways, ultimately leading to progressive retinal ganglion cell (RGC) …

Neuroprotection can be defined as any therapeutic paradigm designed to prevent or delay
neuronal cell death and maintain neural function. In glaucoma, progressive death of the …

While sustained reduction of intraocular pressure (IOP) has been shown to halt and/or delay
the progressive death of retinal ganglion cells (RGCs) in glaucoma, there exists great …

Glaucoma is a progressive neurodegenerative disease of retinal ganglion cells (RGCs)
associated with characteristic axon degeneration in the optic nerve. Clinically, our only …